phase readout
saveNCT06824155: HEAT Trial (HER2 Antibody Therapy With Lutetium-177)
RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Radiopharm Theranostics, Ltd. Phase: EARLY_PHASE1. Conditions: HER2 Gene Mutation, Advanced Solid Tumors
view source ↗
comments(0)
5-min edit window · permanent after that